When being certain matters . . .
Skin cancer is now diagnosed in the doctor’s office by visual inspection of skin lesions. This is notoriously inaccurate, even for experts, leading to many surgical biopsies of benign lesions being done in doctor’s offices and clinics and then sent to pathology labs for examination to determine if they are cancerous or not. Surgical excision is painful, and provokes anxiety as patients await results.
DermDx now offers an elegant solution to this problem: the DDx.
The DDx brings a powerful new diagnostic technology called Multi-Modal Spectroscopy (MMS) to skin cancer diagnosis. It will be an invaluable aid to doctors in diagnosing skin cancer.
Since visual skin cancer diagnosis, depending as it does on what doctors can see with their eyes, is a weak diagnostic indicator, a more powerful one is needed. Many definitive indicators of cancer are not visible to the eye. The DDx uses MMS to look for just such indicators. It sees important things that the eye cannot see, such as enzyme dynamics, tissue micro-architecture, hemoglobin and melanin content, oxygen saturation, cellular metabolism, status of structural proteins such as collagen and elastin, and key indicators of a tumor’s morphology and invasiveness, important potential indicators of diseased tissue.
The DDx is a compact clinical instrument mounted on a wheeled base for easy movement within the examination room. This unit contains all needed optical equipment integrated into a compact easy-to-use package. The system features a hand-held, pen-sized optical probe ( the “light wand”) that the doctor or other qualified clinical professional uses. The wand is the approximate size and shape of a ball-point pen. The distal end is about 2 mm in diameter. The area measured is circle, about 0.5mm diameter in the center of this tip. This enables measurement of lesions much smaller than those that can be reliably assessed by eye. The flexible optical fiber cable that carries light to and from the measured area connects the spectroscopic unit to the proximal end of the probe. Measurement can be triggered either by hand or with a foot-operated switch while the distal end of the probe gently contacts the tissue of concern. Learn more ...
DDx is not yet approved for sale in Europe and US.